Who are Instanosis, Inc.'s investors?

Instanosis, Inc.'s investors include National Institutes of Health.

When was Instanosis, Inc. founded?

Instanosis, Inc. was founded in 2022.

Where is Instanosis, Inc. headquartered?

Instanosis, Inc. is headquartered in Milford, Delaware, United States.

What industry is Instanosis, Inc. in?

Instanosis, Inc. operates in Biotech, Healthcare.

How many employees does Instanosis, Inc. have?

Instanosis, Inc. has 1-10 employees.

Instanosis, Inc.

Test Smarter. Act Faster. Save Lives.

Milford, United States · Founded 2022

Biotech

Healthcare

Headquarters: Milford, Delaware
Employees: 1–10
Founded: 2022
Business Model: B2B

Website: instanosis.com
Last Round: GrantJan 2024
Rounds: 1

About

Instanosis is a biotech diagnostics company developing CLIA-waived, FDA-cleared rapid drug detection tools for hospitals, harm reduction organizations, and forensic teams. The company manufactures lateral flow immunoassay diagnostics for detecting fentanyl, xylazine, nitazenes, and other drugs without requiring laboratory infrastructure. Instanosis serves healthcare systems, emergency responders, and forensic investigators with US-manufactured diagnostic products.

Summary

Instanosis, Inc. is a Biotech company based in Milford, United States, founded in 2022. Its most recent funding was a Grant round in Jan 2024. Investors include National Institutes of Health.